Forest quality has a significant impact on carbon emissions of the economic system. This paper, based on an analysis of the Environmental Kuznets Curve (EKC) of Forest quality and carbon emission of economic systems, explores effective carbon emission reduction paths from the perspective of symbiosis between Forest quality and economic growth system. This paper carries out empirical analysis based on the provincial-level regional data of China and EKC panel data analysis for several major geographic regions in China. The correlation statistical test shows that the model considering Forest quality is more consistent with the test requirements. It is found that the overall EKC curve of China as a whole shows an inverted U-shape. In light of geographic differences, the EKC curve in the northwest also shows an inverted U-shape; it shows a U-shaped curve in North, Northeast, and East China. Meanwhile, in South Central and Southwest China, there is an approximately linear increasing curve. The data simulation of the symbiotic system of Forest quality and economic growth suggests that simultaneously increasing the proportion of forestry output value and the systematic carbon inhibition coefficient is the most effective pathway for carbon emission reduction. Choosing an appropriate carbon reduction pathway can contribute to the sustainable development of Forest quality and economic growth. The main research highlight of this paper is the application of the symbiotic system model to the EKC analysis of carbon emissions from the economic system with Forest quality.

The blood brain barrier (BBB) is an essential component in regulating and maintaining the homeostatic microenvironment of the central nervous system (CNS). During the occurrence and development of glioblastoma (GBM), BBB is pathologically disrupted with markedly increased permeability. Due to the obstruction imposed by the BBB, strategies currently employed for GBM therapeutics still obtain a very low success rate and lead to systemic toxicity. Moreover, chemotherapy could promote pathological BBB functional restoration, accompanied with a prominent decrease of intracerebral therapeutics transportion during GBM multiple administration, resulting in chemotherapy failure for GBM treatment. The effective delivery of therapeutics into the brain still faces with severe challenges. Regulation of pathological BBB for enhanced transporting of therapeutics across the barrier may provide new opportunities for effective and safe treatment of GBM. This article reviews the structure and function of BBB in physiological state, the mechanisms underlying BBB pathological fenestration during the development of GBM, and the therapeutic strategies of GBM based on BBB intervention and therapeutic drugs transporting across the BBB.